Evidence map›Paper›PMID 41806147›Full record

ArticleAdvanced biotechnology2026

Nanopore direct RNA sequencing for RNA modification analysis: workflow assessment and computational tool benchmarking.

Zhixing Wu, Jiayi Li, Rong Xia, Jiayin Dai, Jionglong Su, Jia Meng, Yuxin Zhang

Abstract read
In one paragraph

Article in Advanced biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhixing WuDepartment of Biosciences and Bioinformatics, Center for Intelligent RNA Therapeutics, Suzhou Key Laboratory of Cancer Biology and Chronic Disease, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, 215123, China.
Jiayi LiDepartment of Biosciences and Bioinformatics, Center for Intelligent RNA Therapeutics, Suzhou Key Laboratory of Cancer Biology and Chronic Disease, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, 215123, China.
Rong XiaDepartment of Biosciences and Bioinformatics, Center for Intelligent RNA Therapeutics, Suzhou Key Laboratory of Cancer Biology and Chronic Disease, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, 215123, China.
Jiayin DaiDepartment of Biosciences and Bioinformatics, Center for Intelligent RNA Therapeutics, Suzhou Key Laboratory of Cancer Biology and Chronic Disease, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, 215123, China.
Jionglong SuSchool of AI and Advanced Computing, XJTLU Entrepreneur College, Xi'an Jiaotong-Liverpool University, Suzhou, China.
Jia MengDepartment of Biosciences and Bioinformatics, Center for Intelligent RNA Therapeutics, Suzhou Key Laboratory of Cancer Biology and Chronic Disease, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, 215123, China.
Yuxin ZhangDepartment of Biosciences and Bioinformatics, Center for Intelligent RNA Therapeutics, Suzhou Key Laboratory of Cancer Biology and Chronic Disease, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, 215123, China. zhangyuxin@ibp.ac.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advancements in sequencing technologies have transformed the characterization of genomic and transcriptomic complexity. In this review, we present a comprehensive overview of Oxford Nanopore Technologies (ONT), emphasizing its unique capability for real-time, long-read, and direct RNA sequencing. We begin by outlining the core ONT analytical workflow-base calling, alignment, re-squiggling, and quality control-and summarize the major computational tools applied at each stage. Then extensive illustrations of various RNA modification detection techniques are provided, spanning from statistical models, machine learning and deep learning frameworks to advanced strategies incorporating large language models. To assess methodological performance, additional benchmark analyses of m6A and pseudouridine (Ψ) are carried out across two publicly available datasets. These results demonstrate substantial variability across different tools, underscoring the inherent difficulties in reliably detecting modifications from ONT signals. We further examine the biological roles of key RNA modifications and contrast ONT-based approaches with conventional detection technologies. Finally, we discuss persistent limitations such as sequencing error rates, data and computational demands, and the complexity of multi-modification inference, and further propose future directions aimed at improving accuracy, robustness, and biological interpretability in ONT-based epitranscriptomic research.

Indexed as

Analytical pipelinesBase callingBenchmark analysisComputational toolsDeep learningMachine learningNanopore sequencingRNA modification detection

Identifiers

PMID41806147
PMCPMC12976157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.